Cargando…
Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme
BACKGROUND: Bowel cancer is common and a major cause of death. The NHS is currently rolling out a national bowel cancer screening programme that aims to cover the entire population by 2010. The programme will be based on the Faecal Occult Blood test (FOBt) that reduces mortality from colon cancer by...
Autores principales: | Wilson, Sue, Taskila, Taina, Ismail, Tariq, Stocken, Deborah D, Martin, Ashley, Redman, Val, Wakelam, Michael, Perry, Ian, Hobbs, Richard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639610/ https://www.ncbi.nlm.nih.gov/pubmed/19175925 http://dx.doi.org/10.1186/1471-2407-9-36 |
Ejemplares similares
-
Wolverhampton Hospital for Women
Publicado: (1904) -
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population
por: Wilson, Sue, et al.
Publicado: (2006) -
Improving safety in care homes: protocol for evaluation of the Walsall and Wolverhampton care home improvement programme
por: Damery, Sarah, et al.
Publicado: (2017) -
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
por: Hurst, N G, et al.
Publicado: (2007) -
Reply: Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
por: Hurst, N G, et al.
Publicado: (2008)